Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response

While the role of genus alpha human papillomaviruses in the tumorigenesis and tumor maintenance of anogenital and oropharyngeal cancers is well-established, the role of genus beta human papilloviruses (β-HPVs) in non-melanoma skin cancers (NMSCs) is less certain. Persistent β-HPV infections cause NM...

Full description

Bibliographic Details
Main Authors: Sebastian O. Wendel, Nicholas A. Wallace
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.02250/full
_version_ 1819086320877699072
author Sebastian O. Wendel
Nicholas A. Wallace
author_facet Sebastian O. Wendel
Nicholas A. Wallace
author_sort Sebastian O. Wendel
collection DOAJ
description While the role of genus alpha human papillomaviruses in the tumorigenesis and tumor maintenance of anogenital and oropharyngeal cancers is well-established, the role of genus beta human papilloviruses (β-HPVs) in non-melanoma skin cancers (NMSCs) is less certain. Persistent β-HPV infections cause NMSCs in sun-exposed skin of people with a rare genetic disorder, epidermodysplasia verruciformis. However, β-HPV infections in people without epidermodysplasia verruciformis are typically transient. Further, β-HPV gene expression is not necessary for tumor maintenance in the general population as on average there is fewer than one copy of the β-HPV genome per cell in NMSC tumor biopsies. Cell culture, epidemiological, and mouse model experiments support a role for β-HPV infections in the initiation of NMSCs through a “hit and run” mechanism. The virus is hypothesized to act as a cofactor, augmenting the genome destabilizing effects of UV. Supporting this idea, two β-HPV proteins (β-HPV E6 and E7) disrupt the cellular response to UV exposure and other genome destabilizing events by abrogating DNA repair and deregulating cell cycle progression. The aberrant damage response increases the likelihood of oncogenic mutations capable of driving tumorigenesis independent of a sustained β-HPV infection or continued viral protein expression. This review summarizes what is currently known about the deleterious effects of β-HPV on genome maintenance in the context of the virus's putative role in NMSC initiation.
first_indexed 2024-12-21T21:18:23Z
format Article
id doaj.art-acf8aa6b73204f7a8faf00c4a0c357ad
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-21T21:18:23Z
publishDate 2017-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-acf8aa6b73204f7a8faf00c4a0c357ad2022-12-21T18:49:57ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2017-11-01810.3389/fmicb.2017.02250315330Loss of Genome Fidelity: Beta HPVs and the DNA Damage ResponseSebastian O. WendelNicholas A. WallaceWhile the role of genus alpha human papillomaviruses in the tumorigenesis and tumor maintenance of anogenital and oropharyngeal cancers is well-established, the role of genus beta human papilloviruses (β-HPVs) in non-melanoma skin cancers (NMSCs) is less certain. Persistent β-HPV infections cause NMSCs in sun-exposed skin of people with a rare genetic disorder, epidermodysplasia verruciformis. However, β-HPV infections in people without epidermodysplasia verruciformis are typically transient. Further, β-HPV gene expression is not necessary for tumor maintenance in the general population as on average there is fewer than one copy of the β-HPV genome per cell in NMSC tumor biopsies. Cell culture, epidemiological, and mouse model experiments support a role for β-HPV infections in the initiation of NMSCs through a “hit and run” mechanism. The virus is hypothesized to act as a cofactor, augmenting the genome destabilizing effects of UV. Supporting this idea, two β-HPV proteins (β-HPV E6 and E7) disrupt the cellular response to UV exposure and other genome destabilizing events by abrogating DNA repair and deregulating cell cycle progression. The aberrant damage response increases the likelihood of oncogenic mutations capable of driving tumorigenesis independent of a sustained β-HPV infection or continued viral protein expression. This review summarizes what is currently known about the deleterious effects of β-HPV on genome maintenance in the context of the virus's putative role in NMSC initiation.http://journal.frontiersin.org/article/10.3389/fmicb.2017.02250/fullbeta HPVDNA-damage responseskin cancergenomic fidelitytumorigenesisepidermodysplasia verruciformis
spellingShingle Sebastian O. Wendel
Nicholas A. Wallace
Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
Frontiers in Microbiology
beta HPV
DNA-damage response
skin cancer
genomic fidelity
tumorigenesis
epidermodysplasia verruciformis
title Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
title_full Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
title_fullStr Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
title_full_unstemmed Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
title_short Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
title_sort loss of genome fidelity beta hpvs and the dna damage response
topic beta HPV
DNA-damage response
skin cancer
genomic fidelity
tumorigenesis
epidermodysplasia verruciformis
url http://journal.frontiersin.org/article/10.3389/fmicb.2017.02250/full
work_keys_str_mv AT sebastianowendel lossofgenomefidelitybetahpvsandthednadamageresponse
AT nicholasawallace lossofgenomefidelitybetahpvsandthednadamageresponse